Jiangsu Recbio Technology Co., Ltd. Class H

As of December 31, 2025, Jiangsu Recbio Technology Co., Ltd. Class H carries a market capitalization of 2.50B, placing it among publicly traded companies globally. Its enterprise value stands at 2.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Jiangsu Recbio Technology Co., Ltd. Class H's next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2025, Jiangsu Recbio Technology Co., Ltd. Class H has 626.08M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Jiangsu Recbio Technology Co., Ltd. Class H maintains a current ratio of 1.00, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Jiangsu Recbio Technology Co., Ltd. Class H's stock has declined approximately 45.71% over the past 52 weeks. The 50-day moving average sits at 4.83, while the 200-day moving average is 5.96.

As of December 31, 2025, Jiangsu Recbio Technology Co., Ltd. Class H holds 391.56M in cash and equivalents against 710.55M in total debt, resulting in a net debt position of 298.08M. Total book value stands at 785.52M, with working capital of -96,821.50 providing operational flexibility.